Pasar al contenido principal

DETERMINANTES MOLECULARES IMPLICADOS EN LA UNION/CAPTACION DE EXOSOMAS TUMORALES POR CELULAS RECEPTORAS INMUNES Y NO INMUNES

PID2021-123199OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

Oral squamous cell carcinomas drive monocytes into immunosuppressive CD25+CD163+CD206+ macrophages

  • Peláez Prestel, Héctor Fernando
  • González Martín, Fernando
  • Ras Carmona, Álvaro
  • Rocha, Almudena
  • Cabañas Gutiérrez, Carlos
  • Lafuente Duarte, María Esther
  • Reche Gallardo, Pedro Antonio
Tumor-associated macrophages (TAMs) are major cellular components in the tumor microenvironment of oral squamous cell carcinomas (OSCCs). Most of these TAMs derive from circulating monocytes that differentiate in situ. In this work, we show that cell culture media (CM) derived from two OSCC cell lines, H413 and TR146, promote monocyte differentiation into M2 macrophages, characterized by a high expression of CD163, CD206 and a low expression of CD11c, CD86 and HLA-DR. Monocyte-derived macrophages (moMΦ) differentiated by CM from H413 cells (H413-CM) were also unable to activate allogeneic T cells, and inhibited T cell activation and proliferation induced by CD3/CD28 stimulation. By culturing monocytes with fractionated H413-CM, we found that soluble proteins mediated CD163+CD206+ moMΦ differentiation, discarding a role for small metabolites and extracellular vesicles. Differential proteomic analyses on H413-CM fractions revealed the presence of several proteins, including the complement factor H or plasminogen activator inhibitor 1, as potential candidates to induce CD163+CD206+ moMΦ differentiation. Finally, RNAseq transcriptomic analyses of H413-CM conditioned moMΦ, identified a expression profile signature involving cytokines and cytokine receptors, which surprisingly included IL2RA (encoding CD25). CD25 enhanced expression was confirmed on H143-CM moMΦ. Collectively, these data indicate that the CM from OSCC cell lines promotes the differentiation of functionally immunosuppressive macrophages resembling TAMs, and contributes to the understanding of how OSCCs create an immunosuppressive cellular environment that favors tumor growth.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling

  • Terri, Michela
  • Sandoval, Pilar
  • Bontempi, Giulio
  • Montaldo, Claudia
  • Tomero-Sanz, Henar
  • Turris, Valeria de
  • Trionfetti, Flavia
  • Pascual-Antón, Lucía
  • Clares, Irene
  • Battistelli, Cecilia
  • Valente, Sergio
  • Zwergel, Clemens
  • Mai, Antonello
  • Rosanò, Laura
  • Pozo, Miguel Angel
  • Sánchez-Álvarez, Miguel
  • Cabañas, Carlos
  • Tripodi, Marco
  • López-Cabrera, Manuel
  • Strippoli, Raffaele
[Background]: Peritoneal metastasis, which accounts for 85% of all epithelial ovarian carcinoma (EOC) metastases, is a multistep process that requires the establishment of adhesive interactions between cancer cells and the peritoneal membrane. Interrelations between EOC and the mesothelial stroma are critical to facilitate the metastatic process. No data is available so far on the impact of histone acetylation/deacetylation, a potentially relevant mechanism governing EOC metastasis, on mesothelial cells (MCs)-mediated adhesion., [Methods]: Static adhesion and peritoneal clearance experiments were performed pretreating mesenchymal-like MCs and platinum—sensitive/resistant EOC cell lines with MS-275—a Histone deacetylase (HDAC)1–3 pharmacological inhibitor currently used in combination trials. Results were acquired by confocal microscopy and were analyzed with an automated Opera software. The role of HDAC1/2 was validated by genetic silencing. The role of α4-, α5-α1 Integrins and Fibronectin-1 was validated using specific monoclonal antibodies. Quantitative proteomic analysis was performed on primary MCs pretreated with MS-275. Decellularized matrices were generated from either MS-275-exposed or untreated cells to study Fibronectin-1 extracellular secretion. The effect of MS-275 on β1 integrin activity was assessed using specific monoclonal antibodies. The role of Talin-1 in MCs/EOC adhesion was analyzed by genetic silencing. Talin-1 ectopic expression was validated as a rescue tool from MS-275-induced phenotype. The in vivo effect of MS-275-induced MC remodeling was validated in a mouse model of peritoneal EOC dissemination., [Results]: Treatment of MCs with non-cytotoxic concentrations of MS-275 caused a consistent reduction of EOC adhesion. Proteomic analysis revealed several pathways altered upon MC treatment with MS-275, including ECM deposition/remodeling, adhesion receptors and actin cytoskeleton regulators. HDAC1/2 inhibition hampered actin cytoskeleton polymerization by downregulating actin regulators including Talin-1, impairing β1 integrin activation, and leading to abnormal extracellular secretion and distribution of Fibronectin-1. Talin-1 ectopic expression rescued EOC adhesion to MS-275-treated MCs. In an experimental mouse model of metastatic EOC, MS-275 limited tumor invasion, Fibronectin-1 secretion and the sub-mesothelial accumulation of MC-derived carcinoma-associated fibroblasts., [Conclusion]: Our study unveils a direct impact of HDAC-1/2 in the regulation of MC/EOC adhesion and highlights the regulation of MC plasticity by epigenetic inhibition as a potential target for therapeutic intervention in EOC peritoneal metastasis., This research was funded by: AIRC (Associazione Italiana per la Ricerca sul Cancro) (IG26172) and Ateneo Sapienza Project 2020 (RG120172B8E53D03) to S.V; by FISR2019_00374 MeDyCa to AM; by FSE REACT-EU within the program PON “Research and Innovation” 2014–2020, Action IV.6 “Contratti di ricerca su tematiche Green” to CZ; by SEED PNR 2021 to C.B.; by AIRC IG26290, by Sapienza University of Rome (RG11916B6A9C42C7) to M. Tr and by Ministry for Health of Italy (Ricerca Corrente), by AIRC (IG21372 to LR), by PRIN 2022 PNRR (P2022XZKBM) financed by the European Union - NextGenerationEU», to RS. This work was also supported by grants (PID2019-110132RB-I00/AEI/https://doi.org/10.13039/501100011033 and PID2022-142796OB-I00/AEI/https://doi.org/10.13039/501100011033)) from the Spanish Ministry of Science and Innovation/Fondo Europeo de Desarrollo Regional (MICIN/FEDER) to ML-C and by a grant PID2021-123199OB-I00 from the Spanish Ministry of Science and Innovation/Fondo Europeo de Desarrollo Regional (MICIN/FEDER) to CC. MAdP is recipient/co-recipient of funding from the Spanish Ministry of Science and Innovation (MCIN) (refs. SAF2017–83130-R cofunded by “ERDF A way of making Europe”, PID2020-118658RB-I00, PDC2021–121572-100 cofunded by “European Union NextGeneration EU/PRTR”), Asociación Española Contra el Cáncer foundation (AECC; PROYE20089DELP); La Marató TV3 foundation (201936–30-31), Obra social La Caixa (AtheroConvergence, HR20–00075) and Comunidad Autónoma de Madrid/FEDER (Tec4Bio consortium, ref. S2018/NMT¬4443). MS-A is recipient of a Ramón y Cajal research contract from MCIN (RYC2020–029690-I) and research grant PID2021-128106NA-I00, both from Spanish MCIN. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), and is a Severo Ochoa Center of Excellence (grant CEX2020–001041-S funded by MICIN/AEI/https://doi.org/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020–001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Molecular Determinants Involved in the Docking and Uptake of Tumor-Derived Extracellular Vesicles: Implications in Cancer

  • Clares-Pedrero, Irene
  • Rocha-Mulero, Almudena
  • Palma-Cobo, Miguel
  • Cardeñes, Beatriz
  • Yáñez-Mó, María
  • Cabañas, Carlos
Extracellular vesicles produced by tumor cells (TEVs) influence all stages of cancer development and spread, including tumorigenesis, cancer progression, and metastasis. TEVs can trigger profound phenotypic and functional changes in target cells through three main general mechanisms: (i) docking of TEVs on target cells and triggering of intra-cellular signaling; (ii) fusion of TEVs and target cell membranes with release of TEVs molecular cargo in the cytoplasm of recipient cell; and (iii) uptake of TEVs by recipient cells. Though the overall tumor-promoting effects of TEVs as well as the general mechanisms involved in TEVs interactions with, and uptake by, recipient cells are relatively well established, current knowledge about the molecular determinants that mediate the docking and uptake of tumor-derived EVs by specific target cells is still rather deficient. These molecular determinants dictate the cell and organ tropism of TEVs and ultimately control the specificity of TEVs-promoted metastases. Here, we will review current knowledge on selected specific molecules that mediate the tropism of TEVs towards specific target cells and organs, including the integrins, ICAM-1 Inter-Cellular Adhesion Molecule), ALCAM (Activated Leukocyte Cell Adhesion Molecule), CD44, the metalloproteinases ADAM17 (A Disintegrin And Metalloproteinase member 17) and ADAM10 (A Disintegrin And Metalloproteinase member 10), and the tetraspanin CD9., This study was supported by grants PID2021-123199OB-I00 (to C.C.), PID2020-119627GB-I00 and DTS21/00134 (to M.Y.-M.), funded by the Spanish Ministry of Science, Innovation and Universities (MCIN/AEI/10.13039/501100011033) and by the European Union. I.C.-P.’s salary is funded by the Spanish Ministry of Science, Innovation and Universities (MCIN/AEI/10.13039/501100011033) and by the European Union through its program “Ayudas para Contratos Predoctorales para la Formación de Doctores” (Predoctoral Fellowship: PRE2022-101403). A.R.-M.’s salary is funded by “Comunidad de Madrid” through its program “Ayudas de Personal Investigador Predoctoral en Formación” (Predoctoral Fellowship: PIPF-2022/SAL-GL-24384). The CBMSO is a “Severo Ochoa Center of Excellence” (grant CEX2021-001154-S) funded by MICIN/AEI/10.13039/501100011033 and receives an institutional grant from the Fundación Ramón Areces.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles

  • Cardeñes, Beatriz
  • Clares, Irene
  • Bezos, Tamara
  • Toribio, Víctor
  • López-Martín, Soraya
  • Rocha, Almudena
  • Peinado, Héctor
  • Yáñez-Mó, María
  • Cabañas, Carlos
Colorectal cancer (CRC) and ovarian cancer (OvC) patients frequently develop peritoneal metastasis, a condition associated with a very poor prognosis. In these cancers, tumor-derived extracellular vesicles (EVs) cause immunosuppression, facilitate the direct attachment and invasion of cancer cells through the mesothelium, induce the conversion of peritoneal mesothelial cells (PMCs) into cancer-associated fibroblasts (CAFs) and transfer a more aggressive phenotype amongst cancer cells. Although the promoting role of EVs in CRC and OvC peritoneal metastasis is well established, the specific molecules that mediate the interactions between tumor-derived EVs and immune and non-immune target cells remain elusive. Here, we employed the SKOV-3 (ovarian adenocarcinoma) and Colo-320 (colorectal adenocarcinoma) human cell lines as model systems to study the interactions and uptake of EVs produced by ovarian carcinoma and colorectal carcinoma cells, respectively. We established that the adhesion molecule ALCAM/CD166 is involved in the interaction of cancerderived EVs with recipient cancer cells (a process termed “EV binding” or “EV docking”) and in their subsequent uptake by these cells. The identification of ALCAM/CD166 as a molecule mediating the docking and uptake of CRC and OvC-derived EVs may be potentially exploited to block the peritoneal metastasis cascade promoted by EVs in CRC and OvC patients., This research was funded by the following grants from Agencia Estatal de Investigación (AEI), Ministerio de Ciencia e Innovación (MICINN) and European Fund for Regional Development (FEDER): SAF2016-77096-R and PID2021-123199OB-I00 (C.C.); BIO2017-86500-R and PID2020-119627GB-I00 (M.Y.-M.). B.C.’s salary was funded by grants SAF2016-77096-R and BIO2017-86500-R, from MICINN/FEDER. I.C. and T.B. were supported by “Ayudante de Investigación” contracts PEJ-2019-AI/BMD-12580 and PEJ-2020-AI/BMD-17593, respectively, from “Programa de Empleo Juvenil de la Comunidad de Madrid”.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Expression of the phagocytic receptors αMβ2 and αXβ2 is controlled by RIAM, VASP and Vinculin in neutrophil-differentiated HL-60 cells

  • Torres-Gomez, Álvaro
  • Fiyouzi, Tara
  • Guerra-Espinosa, Claudia
  • Cardeñes, Beatriz
  • Clares, Irene
  • Toribio, Víctor
  • Reche, Pedro A.
  • Cabañas, Carlos
  • Lafuente, Esther M.
Activation of the integrin phagocytic recep, This work has been supported by Ministerio Español de Econoḿıa y Competitividad (MINECO) grants: SAF2016- 77096-R and PID2021-123199OB-I00 (E.L. and C.C.), the CAM (Comunidad Autónoma de Madrid) research agency through grant IND2020/BMD-17364 (P.A.R. and T.F.), and fellowship from MINECO to A. T-G. (FPU15/05349).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Oral squamous cell carcinomas drive monocytes into immunosuppressive CD25+CD163+CD206+ macrophages

  • Pelaez-Prestel, Hector F.
  • Gonzalez-Martin, Fernando
  • Ras-Carmona, Alvaro
  • Rocha, Almudena
  • Cabañas, Carlos
  • Lafuente, Esther M.
  • Reche, Pedro A.
Tumor-associated macrophages (TAMs) are major cellular components in the tumor microenvironment of oral squamous cell carcinomas (OSCCs). Most of these TAMs derive from circulating monocytes that differentiate in situ. In this work, we show that cell culture media (CM) derived from two OSCC cell lines, H413 and TR146, promote monocyte differentiation into M2 macrophages, characterized by a high expression of CD163, CD206 and a low expression of CD11c, CD86 and HLA-DR. Monocyte-derived macrophages (moMΦ) differentiated by CM from H413 cells (H413-CM) were also unable to activate allogeneic T cells, and inhibited T cell activation and proliferation induced by CD3/CD28 stimulation. By culturing monocytes with fractionated H413-CM, we found that soluble proteins mediated CD163CD206 moMΦ differentiation, discarding a role for small metabolites and extracellular vesicles. Differential proteomic analyses on H413-CM fractions revealed the presence of several proteins, including the complement factor H or plasminogen activator inhibitor 1, as potential candidates to induce CD163CD206 moMΦ differentiation. Finally, RNAseq transcriptomic analyses of H413-CM conditioned moMΦ, identified a expression profile signature involving cytokines and cytokine receptors, which surprisingly included IL2RA (encoding CD25). CD25 enhanced expression was confirmed on H143-CM moMΦ. Collectively, these data indicate that the CM from OSCC cell lines promotes the differentiation of functionally immunosuppressive macrophages resembling TAMs, and contributes to the understanding of how OSCCs create an immunosuppressive cellular environment that favors tumor growth., This research was supported by Autonomic Community of Madrid and Spanish research agency for providing financial support through grants IND2020/BMD-17364, PID2021-123199OB-I00 and PID2022-136662OB-100.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The emerging role of human transmembrane RGD-based counter-receptors of integrins in health and disease

  • Cabañas, Carlos
  • Rossi, Elisa
  • Bartolomé, Rubén Álvaro
  • Doberstein, Kai
  • Altevogt, Peter
  • Casal, J. Ignacio
  • Bernabéu, Carmelo
Most of the canonical Arg-Gly-Asp (RGD)-containing integrin ligands are extracellular matrix proteins, such as fibronectin, vitronectin and fibrinogen, which regulate cell-ECM adhesion processes. However, during the last years, several reports have demonstrated the existence of non-canonical RGD-containing integrin ligands that are cell surface transmembrane proteins. At variance with the canonical extracellular matrix integrin ligands, the RGD-containing cell surface integrin ligands are involved in cell-cell adhesion processes and function as "integrin counter-receptors". We propose in this review grouping these transmembrane proteins, which include endoglin, cadherin-5, cadherin-6, cadherin-17, ADAM15, and L1CAM, under the newly coined acronym RGD-ICRs (RGD-containing Integrin Counter-Receptors). We present and discuss the structure of RGD-ICRs, their RGD-based interactions with integrins, the specific signaling pathways triggered in different cell types, as well as their pathophysiological involvement. It can be postulated that RGD-ICRs constitute an emerging group of non-canonical RGD-based integrin counter-receptors. In spite of being encoded by different and independent genes and involved in different pathophysiological processes, all of them appear to have undergone a strong evolutionary convergence in order to acquire the same functional capacity to bind integrins via the RGD motif. Importantly, these RGD-ICRs are also emerging as novel biomarkers and therapeutic targets, with promising clinical potential in a wide array of pathologies., C.C. was supported by grant no. PID2021-123199OB-I00 of the Ministerio de Ciencia e Innovaci\u00F3n (Spain) (MCIN/AEI/https://doi.org/10.13039/501100011033) and by the European Union. The CBM-SO is a \u201CSevero Ochoa Center of Excellence\u201D (grant no. CEX2021-001154-S) funded by MICIN/AEI/https://doi.org/10.13039/501100011033 and receives an institutional grant from the Fundaci\u00F3n Ram\u00F3n Areces. J.I.C. was supported by grant nos. PID2021-122227OB-I00 of the Ministerio de Ciencia e Innovaci\u00F3n (Spain) and PMPTA22/00108 from the Instituto de Salud Carlos III using Next Generation EU/PRTR funds from the MCIN/AEI/https://doi.org/10.13039/501100011033. C.B. was supported by the Consejo Superior de Investigaciones Cient\u00EDficas (CSIC, Spain) (grant no. 201920E022)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Optimizing standardized lab-grown skin substitutes evidences a proliferation-differentiation switch based on ascorbic acid

  • Molina-Oviedo, Angie Katherine
  • Sorrentino, Ilaria
  • Clares-Pedrero, Irene
  • Salamanca-Gonzalez, Celina
  • Arevalo-Nuñez de Arenas, Eduardo
  • Mazariegos, Marina S.
  • Cabañas, Carlos
  • Medraño-Fernandez, Iria
Developing standardized bioengineered constructs that accurately replicate human skin is a largely sought-after goal. Pathways initiated at the nurturing interface with the dermal compartment have the potential to modulate the developing epidermal architecture. Here, we identified ascorbic acid, a dermis-donated metabolite, as key in modulating the phenotypical identity of immortalized keratinocytes. Priming monolayers with 2 μg/mL of the culture-stable derivative L-ascorbic acid 2-phosphate (A2P) led to the emergence of a basal-like phenotype within the cells, which showed increased clonogenicity, nuclear/cytoplasmic ratio, and upregulation of progenitor markers. Instead, surpassing this dose induced intracellular ascorbic acid accumulation and promoted a motile status. In organotypic cultures, pre-incubation of founding keratinocytes with 2 μg/mL of A2P improved epithelial layering, whereas higher pretreatments resulted in poor stratification. These findings suggest that ascorbic acid levels in the self-renewing epithelium have a fundamental role in determining whether cells initially commit to differentiation, ultimately influencing regenerative outcomes., This work was supported through grants from the Madrid Government (Comunidad de Madrid) under the multiannual agreement with UC3M in the line of “Research Funds for Beatriz Galindo Fellowships” (REDOXSKIN-CM-UC3M to I.M.-F.), and in the context of the V PRICIT (Regional Programme of Research and Technological Innovation), and by “Proyectos de I + D + I” (PID2020-114230 GA-I00 to I.M.-F.) funded by MICIU/AEI/10.13039/501100011033/. A.K.M.-O. was supported by a UC3M-PhD research training scholarship (PIPF), and I.S. has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Action Individual postdoctoral fellowship (grant agreement No [101111496]). C.C. is supported by “Proyectos de I + D + I” (PID2021-123199OB-I00 to C.C.), funded by the Spanish Ministry of Science, Innovation and Universities (MICIU/AEI/10.13039/501100011033) and by the European Union. I.C.-P.’s salary is funded by the Spanish Ministry of Science, Innovation and Universities (MICIU/AEI/10.13039/501100011033) and by the European Union through its program “Ayudas para Contratos Predoctorales para la Formación de Doctores” (Predoctoral Fellowship: PRE2022-101403). The CBMSO, in whose installations we performed part of this work, is a “Severo Ochoa Center of Excellence” (grant CEX2021-001154-S) funded by MICIU/AEI/10.13039/501100011033 and also receives an institutional grant from the Fundación Ramón Areces.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Special Issue “Editorial Board Members’ Collection Series: Cancer Metastasis”

  • Cabañas, Carlos
This article belongs to the Special Issue Editorial Board Members’ Collection Series: Cancer Metastasis, Cancer metastasis is the process by which neoplastic cells from a primary tumor spread to distant sites, where cancer cells establish and form new tumors, termed secondary tumors or metastases [...], Carlos Cabañas is supported by grant no. PID2021-123199OB-I00 of the Ministerio de Ciencia e Innovación (Spain) (MCIN/AEI/https://doi.org/10.13039/501100011033) and by the European Union. The CBM-SO is a “Severo Ochoa Center of Excellence” (grant no. CEX2021-001154-S) funded by MICIN/AEI/https://doi.org/10.13039/501100011033 and is also supported by an institutional grant from the Fundación Ramón Areces., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

Expression of the phagocytic receptors αMβ2 and αXβ2 is controlled by RIAM, VASP and Vinculin in neutrophil-differentiated HL-60 cells

  • Torres Gómez, Álvaro
  • Fiyouzi, Tara
  • Guerra Espinosa, Claudia
  • Cardeñes, Beatriz
  • Clares, Irene
  • Toribio, Víctor
  • Reche Gallardo, Pedro Antonio
  • Cabañas Gutiérrez, Carlos
  • Lafuente Duarte, María Esther
Activation of the integrin phagocytic receptors CR3 (αMβ2, CD11b/CD18) and CR4 (αXβ2, CD11c/CD18) requires Rap1 activation and RIAM function. RIAM controls integrin activation by recruiting Talin to β2 subunits, enabling the Talin-Vinculin interaction, which in term bridges integrins to the actin-cytoskeleton. RIAM also recruits VASP to phagocytic cups and facilitates VASP phosphorylation and function promoting particle internalization. Using a CRISPR-Cas9 knockout approach, we have analyzed the requirement for RIAM, VASP and Vinculin expression in neutrophilic-HL-60 cells. All knockout cells displayed abolished phagocytosis that was accompanied by a significant and specific reduction in ITGAM (αM), ITGAX (αX) and ITGB2 (β2) mRNA, as revealed by RT-qPCR. RIAM, VASP and Vinculin KOs presented reduced cellular F-actin content that correlated with αM expression, as treatment with the actin filament polymerizing and stabilizing drug jasplakinolide, partially restored αM expression. In general, the expression of αX was less responsive to jasplakinolide treatment than αM, indicating that regulatory mechanisms independent of F-actin content may be involved. The Serum Response Factor (SRF) was investigated as the potential transcription factor controlling αMβ2 expression, since its coactivator MRTF-A requires actin polymerization to induce transcription. Immunofluorescent MRTF-A localization in parental cells was primarily nuclear, while in knockouts it exhibited a diffuse cytoplasmic pattern. Localization of FHL-2 (SRF corepressor) was mainly sub-membranous in parental HL-60 cells, but in knockouts the localization was disperse in the cytoplasm and the nucleus, suggesting RIAM, VASP and Vinculin are required to maintain FHL-2 close to cytoplasmic membranes, reducing its nuclear localization and inhibiting its corepressor activity. Finally, reexpression of VASP in the VASP knockout resulted in a complete reversion of the phenotype, as knock-ins restored αM expression. Taken together, our results suggest that RIAM, VASP and Vinculin, are necessary for the correct expression of αMβ2 and αXβ2 during neutrophilic differentiation in the human promyelocytic HL-60 cell line, and strongly point to an involvement of these proteins in the acquisition of a phagocytic phenotype.